OnabotulinumtoxinA injections for atypical odontalgia: an open-label study on nine patients

OnabotulinumtoxinA injections for atypical odontalgia: an open-label study on nine patients

Rafael García-Sáez,1 Álvaro Gutiérrez-Viedma1,2 Nuria González-García,1 Víctor Gómez-Mayordomo,1 Jesús Porta-Etessam,1,2 María-Luz Cuadrado1,2 1Headache Unit, Department of Neurology, Instit...

Full description

Bibliographic Details
Main Authors:	García-Sáez R, Gutiérrez-Viedma Á, González-García N, Gómez-Mayordomo V, Porta-Etessam J, Cuadrado ML
Format:	Article
Language:	English
Published:	Dove Medical Press 2018-08-01
Series:	Journal of Pain Research
Subjects:	Atypical odontalgia Neuropathic pain OnabotulinumtoxinA Orofacial pain Painful trigeminal neuropathy Persistent idiopathic facial pain.
Online Access:	https://www.dovepress.com/onabotulinumtoxina-injections-for-atypical-odontalgia-an-open-label-st-peer-reviewed-article-JPR

Similar Items

Pharmacotherapeutic outcomes in atypical odontalgia: determinants of pain relief
by: Tu TTH, et al.
Published: (2019-02-01)

Long-Term Efficacy and Safety of Repeated Intravescial OnabotulinumtoxinA Injections Plus Hydrodistention in the Treatment of Interstitial Cystitis/Bladder Pain Syndrome
by: Cheng-Ling Lee, et al.
Published: (2015-10-01)

latrogenic Pulpal Injury Masquerading as Atypical Odontalgia
by: Praveena Tantradi
Published: (2011-01-01)

Facial pain - An enigma
by: Geeta Rajput, et al.
Published: (2014-01-01)

Evidencia y experiencia del uso de onabotulinumtoxinA en neuralgia del trigémino y cefaleas primarias distintas de la migraña crónica
by: S. Santos-Lasaosa, et al.
Published: (2020-10-01)

Clinical features of atypical odontalgia; three cases and literature reviews
by: Miho Takenoshita, et al.
Published: (2017-08-01)

Efficacy and Safety of Intravesical OnabotulinumtoxinA Injection in Patients with Detrusor Hyperactivity and Impaired Contractility
by: Chung-Cheng Wang, et al.
Published: (2016-03-01)

Peripheral neurectomy in treatment of trigeminal neuralgia: A case report
by: Abhijeet Alok, et al.
Published: (2017-01-01)

Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation
by: Lars Bendtsen, et al.
Published: (2018-09-01)

OnabotulinumtoxinA for chronic migraine during pregnancy: a real world experience on 45 patients
by: Ho-Tin Wong, et al.
Published: (2020-10-01)

High efficacy of onabotulinumtoxinA treatment in patients with comorbid migraine and depression: a meta-analysis
by: Oreste Affatato, et al.
Published: (2021-03-01)

Effects of onabotulinumtoxinA treatment in patients with and without allodynia: results of the COMPEL study
by: William B. Young, et al.
Published: (2019-01-01)

The Orofacial Pain Clinic Questionnaire (EDOF-HC) in the evaluation and diagnosis of orofacial pain
by: Silvia Regina Dowgan Tesseroli de SIQUEIRA, et al.

Pathological Mechanisms and Therapeutic Targets for Trigeminal Neuropathic Pain
by: Pawan Bista, et al.
Published: (2019-08-01)

Avaliação de pacientes com odontalgia atípica perante Teste Sensorial Quantitativo (QST) e Teste de Controle de Modulação da Dor (CPM)
by: André Luís Porporatti
Published: (2013)

Avaliação de pacientes com odontalgia atípica perante Teste Sensorial Quantitativo (QST) e Teste de Controle de Modulação da Dor (CPM)
by: Porporatti, André Luís
Published: (2013)

Potential Molecular Targets for Treating Neuropathic Orofacial Pain Based on Current Findings in Animal Models
by: Yukinori Nagakura, et al.
Published: (2021-06-01)

Botulinum Neurotoxin A Intravesical Injections in Interstitial Cystitis/Bladder Painful Syndrome: A Systematic Review with Meta-Analysis
by: Antonella Giannantoni, et al.
Published: (2019-08-01)

The effect of spinal cord-injury level on the outcome of neurogenic bladder treatment using OnabotulinumtoxinA
by: Waleed Al Taweel, et al.
Published: (2015-01-01)

von Brunn's Nests and Follicular Cystitis Following Intradetrusor OnabotulinumtoxinA Injections for Overactive Bladder
by: Silpa Nekkanti, et al.
Published: (2017-09-01)

OnabotulinumtoxinA: An Effective Tool in the Therapeutic Arsenal for Chronic Migraine With Medication Overuse
by: Edoardo Caronna, et al.
Published: (2018-10-01)

Rehabilitation plus OnabotulinumtoxinA Improves Motor Function over OnabotulinumtoxinA Alone in Post-Stroke Upper Limb Spasticity: A Single-Blind, Randomized Trial
by: Deidre Devier, et al.
Published: (2017-07-01)

Manganese-enhanced MRI reveals changes within brain anxiety and aversion circuitry in rats with chronic neuropathic pain- and anxiety-like behaviors
by: Sabrina L. McIlwrath, et al.
Published: (2020-12-01)

Accuracy of the painDETECT screening questionnaire for detection of neuropathic components in hospital-based patients with orofacial pain: a prospective cohort study
by: Daniyal J Jafree, et al.
Published: (2018-11-01)

OnabotulinumtoxinA Is an Effective Treatment for Chronic Migraine in Patients With Comorbid Fibromyalgia
by: María Sastre Real, et al.
Published: (2020-10-01)

Challenges of Misdiagnosis and Suboptimal Treatment of Persistent Idiopathic Facial Pain and Atypical Odontalgia: A Retrospective Multi-Centric Cross-Sectional Investigation
by: Xiao X, et al.
Published: (2020-11-01)

The impact of onabotulinumtoxinA on severe headache days: PREEMPT 56-week pooled analysis
by: Manjit Matharu, et al.
Published: (2017-08-01)

Therapeutic Efficacy of onabotulinumtoxinA Delivered Using Various Approaches in Sensory Bladder Disorder
by: Po-Yen Chen, et al.
Published: (2020-01-01)

Real-life use of onabotulinumtoxinA reduces healthcare resource utilization in individuals with chronic migraine: the REPOSE study
by: Katja Kollewe, et al.
Published: (2021-06-01)

Iron Deposits in Periaqueductal Gray Matter Are Associated with Poor Response to OnabotulinumtoxinA in Chronic Migraine
by: Clara Domínguez Vivero, et al.
Published: (2020-07-01)

Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study
by: Andrew M. Blumenfeld, et al.
Published: (2018-02-01)

Evidence of and experience with the use of onabotulinumtoxinA in trigeminal neuralgia and primary headaches other than chronic migraine
by: S. Santos-Lasaosa, et al.
Published: (2020-10-01)

Orofacial pain: A critical appraisal in management
by: Shatavisa Mukherjee, et al.
Published: (2015-01-01)

Treatment of Chronic Migraine with OnabotulinumtoxinA: Mode of Action, Efficacy and Safety
by: Délia Szok, et al.
Published: (2015-07-01)

Patient with Chronic Orofacial Pain in a Private Dental Office - Diagnostic Dilemmas
by: Todorovic Ljubomir
Published: (2016-07-01)

Odontalgia Atípica – Revisão de Literatura
by: Márcia Elisa PERONDI, et al.
Published: (2007-03-01)

Economic consequences of migraine in Sweden and implications for the cost-effectiveness of onabotulinumtoxinA (Botox) for chronic migraine in Sweden and Norway
by: Amanda Hansson-Hedblom, et al.
Published: (2020-08-01)

An open-label prospective study of the real-life use of onabotulinumtoxinA for the treatment of chronic migraine: the REPOSE study
by: Fayyaz Ahmed, et al.
Published: (2019-03-01)

Neuropathic Characteristics In Patients With Persistent Idiopathic Facial Pain
by: Sukenaga N, et al.
Published: (2019-09-01)

Effects of onabotulinumtoxinA treatment in chronic migraine patients with and without daily headache at baseline: results from the COMPEL Study
by: William B. Young, et al.
Published: (2019-02-01)

Cannot write session to /tmp/vufind_sessions/sess_3aich900qgjla9t0dglmhftnva